Metropolitan Life Insurance CO Global Blood Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Jun 14, 2023
BUY
$32.4 - $68.18 $127,040 - $267,333
3,921 New
3,921 $267 Million
Q2 2022

Jun 20, 2023
BUY
$22.3 - $37.39 $87,438 - $146,606
3,921 New
3,921 $125,000
Q1 2022

Jun 20, 2023
BUY
$25.68 - $35.59 $100,691 - $139,548
3,921 New
3,921 $135,000
Q1 2022

Mar 30, 2023
SELL
$25.68 - $35.59 $326,058 - $451,886
-12,697 Reduced 76.41%
3,921 $135,000
Q1 2022

May 12, 2022
SELL
$25.68 - $35.59 $326,058 - $451,886
-12,697 Reduced 76.41%
3,921 $136,000
Q4 2021

Jun 21, 2023
BUY
$24.9 - $40.26 $413,788 - $669,040
16,618 New
16,618 $486,000
Q3 2021

Jun 21, 2023
BUY
$25.48 - $37.34 $423,426 - $620,516
16,618 New
16,618 $423,000
Q2 2021

Jun 21, 2023
BUY
$32.46 - $43.42 $539,420 - $721,553
16,618 New
16,618 $581,000
Q2 2021

Mar 30, 2023
BUY
$32.46 - $43.42 $399,420 - $534,283
12,305 Added 285.3%
16,618 $581,000
Q2 2021

Aug 16, 2021
BUY
$32.46 - $43.42 $539,290 - $721,379
16,614 Added 415350.0%
16,618 $582,000
Q1 2021

Jun 26, 2023
BUY
$38.94 - $50.85 $167,948 - $219,316
4,313 New
4,313 $176 Million
Q1 2021

Mar 30, 2023
SELL
$38.94 - $50.85 $7,593 - $9,915
-195 Reduced 4.33%
4,313 $175,000
Q1 2021

May 14, 2021
SELL
$38.94 - $50.85 $175,385 - $229,028
-4,504 Reduced 99.91%
4 $176,000
Q4 2020

Jun 22, 2023
BUY
$37.65 - $63.77 $169,726 - $287,475
4,508 New
4,508 $195,000
Q4 2020

Mar 30, 2023
SELL
$37.65 - $63.77 $903 - $1,530
-24 Reduced 0.53%
4,508 $195,000
Q4 2020

Feb 16, 2021
SELL
$37.65 - $63.77 $903 - $1,530
-24 Reduced 0.53%
4,508 $195,000
Q3 2020

Jun 26, 2023
BUY
$52.76 - $74.49 $239,108 - $337,588
4,532 New
4,532 $249,000
Q3 2020

Mar 30, 2023
SELL
$52.76 - $74.49 $6,172 - $8,715
-117 Reduced 2.52%
4,532 $249,000
Q3 2020

Nov 13, 2020
SELL
$52.76 - $74.49 $6,172 - $8,715
-117 Reduced 2.52%
4,532 $250,000
Q2 2020

Jun 26, 2023
BUY
$48.73 - $81.82 $226,545 - $380,381
4,649 New
4,649 $293,000
Q2 2020

Mar 30, 2023
SELL
$48.73 - $81.82 $633,002 - $1.06 Million
-12,990 Reduced 73.64%
4,649 $293,000
Q2 2020

Aug 14, 2020
SELL
$48.73 - $81.82 $633,002 - $1.06 Million
-12,990 Reduced 73.64%
4,649 $293,000
Q1 2020

Jul 12, 2023
BUY
$41.72 - $87.2 $735,899 - $1.54 Million
17,639 New
17,639 $901,000
Q1 2020

Mar 30, 2023
BUY
$41.72 - $87.2 $8,969 - $18,748
215 Added 1.23%
17,639 $901,000
Q1 2020

May 15, 2020
BUY
$41.72 - $87.2 $8,969 - $18,748
215 Added 1.23%
17,639 $901,000
Q4 2019

Jul 12, 2023
BUY
$45.7 - $81.86 $796,276 - $1.43 Million
17,424 New
17,424 $1.39 Million
Q4 2019

Mar 30, 2023
SELL
$45.7 - $81.86 $24,632 - $44,122
-539 Reduced 3.0%
17,424 $1.39 Million
Q4 2019

Feb 14, 2020
SELL
$45.7 - $81.86 $24,632 - $44,122
-539 Reduced 3.0%
17,424 $1.39 Million
Q3 2019

Jul 12, 2023
BUY
$45.35 - $57.91 $814,622 - $1.04 Million
17,963 New
17,963 $871,000
Q3 2019

Mar 30, 2023
BUY
$45.35 - $57.91 $49,431 - $63,121
1,090 Added 6.46%
17,963 $871,000
Q3 2019

Nov 14, 2019
BUY
$45.35 - $57.91 $49,431 - $63,121
1,090 Added 6.46%
17,963 $872,000
Q2 2019

Jul 12, 2023
BUY
$52.6 - $63.29 $902,405 - $1.09 Million
17,156 New
17,156 $902,000
Q1 2019

Jul 13, 2023
BUY
$39.99 - $53.48 $674,751 - $902,368
16,873 New
16,873 $893,000
Q1 2019

Mar 30, 2023
BUY
$39.99 - $53.48 $674,751 - $902,368
16,873 New
16,873 $893,000
Q1 2019

May 16, 2019
BUY
$39.99 - $53.48 $107,053 - $143,165
2,677 Added 18.86%
16,873 $893,000
Q1 2019

May 15, 2019
SELL
$39.99 - $53.48 $84,578 - $113,110
-2,115 Reduced 12.97%
14,196 $2.59 Million
Q4 2018

Jul 13, 2023
BUY
$31.54 - $46.67 $514,448 - $761,234
16,311 New
16,311 $669,000
Q4 2018

Feb 14, 2019
BUY
$31.54 - $46.67 $401,788 - $594,529
12,739 Added 356.63%
16,311 $670,000
Q3 2018

Jul 13, 2023
BUY
$38.0 - $51.1 $619,818 - $833,492
16,311 New
16,311 $620 Million
Q3 2018

Nov 14, 2018
SELL
$38.0 - $51.1 $484,082 - $650,962
-12,739 Reduced 78.1%
3,572 $136,000
Q2 2018

Aug 15, 2018
BUY
$38.7 - $50.15 $155,961 - $202,104
4,030 Added 32.81%
16,311 $0
Q1 2018

May 15, 2018
BUY
$39.6 - $65.9 $8,514 - $14,168
215 Added 1.78%
12,281 $0
Q4 2017

Feb 15, 2018
SELL
$29.7 - $45.7 $398,752 - $613,568
-13,426 Reduced 52.67%
12,066 $475,000
Q2 2017

Aug 14, 2017
BUY
N/A
25,492
25,492 $697,000

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email